The present invention is directed to a composition comprising from 0.1 to 10.0 wt % of a mixture of glycosaminoglycans comprising dermatan sulfate and chondroitin sulfate, wherein the amount of dermatan sulfate is at least 5% and not more than 95 % by weight, and the amount of chondroitin sulfate is at least 5% and not more than 95 % by weight, based on the total amount of glycosaminoglycans. Furthermore, the invention is also directed to the use of a glycosaminoglycans composition comprising dermatan sulfate and chondroitin sulfate, wherein the amount of dermatan sulfate is at least 5% and not more than 95 % by weight, and the amount of chondroitin sulfate is at least 5% and not more than 95 % by weight, based on the total amount of glycosaminoglycans, as an anti-age composition.
